A Phase 1b Study to Evaluate the Safety of XEN-101

A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight

NCT04667377 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 Trials of NA-931 to Study Subjects Who Are Obese With at Least One Weight-related Comorbid Condition

NCT06564753 ·Status: COMPLETED ·Phase: PHASE2

Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions

NCT06867718 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

NCT02159729 ·Status: COMPLETED ·Phase: PHASE2

Phase 1 to Study Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NA-931 in Obese Participants and Patients With Type 2 Diabetes Mellitus

NCT06615700 ·Status: COMPLETED ·Phase: PHASE1

Evaluate the Safety and Efficacy of CPX101 in Overweight and Obese Subjects Without Diabetes Mellitus

NCT06532578 ·Status: COMPLETED ·Phase: PHASE2

Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying

NCT02160990 ·Status: COMPLETED ·Phase: PHASE4

Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity

NCT03308721 ·Status: COMPLETED ·Phase: PHASE1

A Safety and Tolerability Study of 10XB-101 Injections in Adult Subjects With Extra Fat Under the Chin ("Double Chin")

NCT04258761 ·Status: COMPLETED ·Phase: PHASE2

One-Year Study of S1B-509 vs Placebo for Weight Loss

NCT06517797 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus

NCT05814107 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Study of NGM313 in Healthy Adult Participants

NCT02708576 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of ZT006 in Overweight and Obese Participants

NCT07230132 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range

NCT05564117 ·Status: COMPLETED ·Phase: PHASE3

Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie Diet

NCT00747929 ·Status: COMPLETED ·Phase: PHASE2

The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects

NCT01719419 ·Status: WITHDRAWN ·Phase: NA

Safety, Tolerability and Pharmacokinetics of Multiple Doses of ZGN-433 in Obese Female Volunteers

NCT01028261 ·Status: COMPLETED ·Phase: PHASE1

A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity

NCT04010786 ·Status: COMPLETED ·Phase: PHASE1

Multifactorial Approach Associated With Orlistat (Xenical) for 4 Years Weight Loss Maintenance in Obese Adults

NCT02706067 ·Status: COMPLETED ·Phase: PHASE4

The Effect of Xenical on Weight and Risk Factors

NCT00152360 ·Status: COMPLETED ·Phase: PHASE4

Phase II Study of THDBH120 Injection in Overweight or Obese Subjects

NCT07036601 ·Status: RECRUITING ·Phase: PHASE2

Phase I Study of XTL6001 Injection in Healthy and Obese Subjects

NCT07205432 ·Status: RECRUITING ·Phase: PHASE1

Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity

NCT03661879 ·Status: COMPLETED ·Phase: PHASE1

STUDY TO COMPARE PHARMACOKINETICS (PK) OF SINGLE ORAL DOSES OF DIFFERENT PF-06882961 FORMULATIONS IN PARTICIPANTS WHO ARE OVERWEIGHT OR HAVE OBESITY

NCT04616339 ·Status: COMPLETED ·Phase: PHASE1

A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants After 10 Days of Oral Dosing

NCT06820476 ·Status: COMPLETED ·Phase: PHASE1